Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES
GLOBETECH PUBLISHING LLC

Blood Test Diagnoses Cause of Kidney Failure

By Labmedica International staff writers
Posted on 01 Feb 2012
Discoveries about the basic workings of endothelial cells could lead to a diagnostic test for the serious kidney disease known as hemolytic uremic syndrome (HUS).

HUS is a potentially life-threatening condition and often occurs after gastrointestinal infection with Escherichia coli O157:H7, which produces Shiga toxins (Stx) that cause hemolytic anemia, thrombocytopenia, and renal injury.

Scientists at University of Toronto (ON, Canada) discovered a biological pathway never before known to have played a role in the development of HUS. Specifically, they found that the toxin can increase the level of a chemokine, namely stromal cell-derived factor-1 (SDF-1), and its receptor, C-X-C chemokine receptor type 4 (CXCR4). Chemokines are small secreted proteins that stimulate cells to move or migrate. CXCR4 was already known to stimulate the release and migration of the precursors of white blood cells from bone marrow, to change how blood vessels grow and to help the AIDS virus enter cells.

Blood tests were performed on children with E. coli and all measurements of SDF-1 were performed on blinded samples by a sandwich enzyme-linked immunosorbent assay (ELISA) (R&D Systems, Minneapolis, MN, USA). The results indicated that those who went on to develop HUS had as much as four times higher levels of the protein SDF-1, than other children with E. coli who did not go on to develop HUS. This suggests that a blood test could be used to predict who is most likely to develop the potentially fatal HUS, meaning they could be monitored more closely. The scientists found that too much communication between SDF-1 and CXCR4 molecules can also impact the development of HUS in animals and humans.

Philip A. Marsden, MD, FRCPC, who is a nephrologist at Saint Michael’s Hospital (Toronto, ON, Canada) and senior author of the study, said, "A safe water supply and clean food supply chain is the most important step in preventing HUS caused by E. coli. If we can measure SDF-1 levels in real time during an E. coli outbreak and confirm these findings, then we have a strong case for a trial of CXCR4 antagonists in patients with toxin-producing E. coli to see if it prevents or improves cases of HUS.” The study was published on January 9, 2012, in the Journal of Clinical Investigation.

Related Links:
University of Toronto
R&D Systems
Saint Michael’s Hospital


KARL HECHT GMBH & CO KG
MEDLAB Asia
CELLAVISION AB

Channels

Genetic Tests

view channel
Image: For each chromosome, key SNPs are displayed above the chromosome and non-key SNPs below the chromosome, enabling users to determine the accuracy of haploblock calling. SNPs failed to be called are displayed as white points in the middle of the chromosome (Photo courtesy of Illumina).

Karyomapping Proposed as Alternative to Preimplantation Genetic Diagnosis for Evaluation of IVF Embryos

British researchers have suggested that karyomapping is a viable and cost-effective method for detecting a wide range of genetic diseases in IVF (in vitro fertilization) embryos. Preimplantation Genetic... Read more

Industry News

view channel
Image: Positive case of lung tissue stained for ALK with VENTANA ALK (D5F3) CDx Assay, a companion diagnostic immunohistochemical test in the final stages of the FDA premarket approval process (Photo courtesy of Ventana Medical Systems and PRNewsFoto).

Premarket Approval Sought for CDx Test to Benefit Lung Cancer Patients

Ventana Medical Systems, Inc. (Tucson, AZ, USA) has announced its US Food & Drug Administration (FDA) final stage submission for premarket approval (PMA) of its companion diagnostic (CDx) immunohistochemistry... Read more
 

Events

05 Mar 2015 - 08 Mar 2015
18 Mar 2015 - 20 Mar 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.